The purpose of this protocol is to determine user preferences for antiretroviral therapy
(ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected
partners and to optimize targeted delivery and sustained use of these interventions.
Phase:
Phase 4
Details
Lead Sponsor:
University of Washington
Collaborators:
Bill and Melinda Gates Foundation National Institute of Mental Health (NIMH) United States Agency for International Development (USAID)